Canterbury DHB
don't forget to update the issue and next review variables!!!
Changes in this release |
||
Topic or section |
Brief description |
Reviewer |
Removed mention of ESR testing for AML/APL. |
Ruth Spearing |
|
Removed topics that are also in Blue Book and replaced them with link to Blue Book. |
Emma Harding |
|
Added link to a review of TLS. |
Andrew Butler |
|
Cancer Exceptional Circumstances is now Named Patient Pharmaceutical Assessment (NPPA), and anagrelide doesn't require SA. |
Bevan Harden |
Topic Code: 71348